Consun Pharmaceutical Group Limited - 1681.HK

1681.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
1681.HK	1.0	3.5	-0.1	-2.8	34.4	56.2	93.5	95.5	28.4	58.8
S&P 500	1.0	0.6	1.1	2.4	8.9	23.6	36.4	80.6	195.1	33856.2

Compare 1681.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	1681.HK
name	Consun Pharmaceutical Group Limited
price	7.78
changes percentage	1.039
change	0.08
day low	7.71
day high	7.78
year high	8.88
year low	4.95
market cap	6464596500
price avg 50	7.9666
price avg 200	6.70865
exchange	HKSE
volume	3571404
avg volume	1776611
open	7.77
previous close	7.7
eps	1.1
pe	7.07
earnings announcement	2025-03-19T12:00:00.000+0000
shares outstanding	830925000
timestamp	2025-01-21 08:08:04

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 65.3%

Overall Quarterly Financial Health: 35.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	2590115000	2339650000	10.71
gross profit	1921678000	1762912000	9.01
gross profit ratio	0.74	0.75	-1.54
research and development expenses	108535000	117539000	-7.66
operating expenses	1036711000	1058000000	-2.01
interest income	68917000	41481000	66.14
interest expense	21264000	10933000	94.49
ebitda	963056000	785888000	22.54
ebitdaratio	0.37	0.34	10.69
operating income	884967000	715408000	23.70
operating income ratio	0.34	0.31	11.74
net income	784534000	682907000	14.88
net income ratio	0.3	0.29	3.77
eps	0.98	0.86	13.95

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,590 million in 2023 from 2,340 million in 2022 representing a change of 10.71%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,922 million in 2023 from 1,763 million in 2022 representing a change of 9.01%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 1,037 million in 2023 from 1,058 million in 2022 representing a change of -2.01%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 963 million in 2023 from 786 million in 2022 representing a change of 22.54%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 885 million in 2023 from 715 million in 2022 representing a change of 23.7%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 785 million in 2023 from 683 million in 2022 representing a change of 14.88%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.98 in 2023 from 0.98 in 2022 representing a change of 13.95%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 109 million in 2023 from 118 million in 2022 representing a change of -7.66%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	1268549000	1470436000	-13.73
gross profit	947523000	1085262000	-12.69
gross profit ratio	0.75	0.74	1.20
research and development expenses	40953000	60573000	-32.39
operating expenses	500190000	585107000	-14.51
interest income	0	22412000	-100.00
interest expense	0	0	NaN
ebitda	453509000	501950000	-9.65
ebitdaratio	0.36	0.34	4.73
operating income	447333000	500155000	-10.56
operating income ratio	0.35	0.34	3.67
net income	399765000	436640000	-8.45
net income ratio	0.32	0.3	6.13
eps	0.49	0.54	-9.26

Overall Score of Quarterly Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,269 million in 2024Q2 from 1,470 million in 2023Q4 representing a change of -13.73%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 948 million in 2024Q2 from 1,085 million in 2023Q4 representing a change of -12.69%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 41 million in 2024Q2 from 61 million in 2023Q4 representing a change of -32.39%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 454 million in 2024Q2 from 502 million in 2023Q4 representing a change of -9.65%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 447 million in 2024Q2 from 500 million in 2023Q4 representing a change of -10.56%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 400 million in 2024Q2 from 437 million in 2023Q4 representing a change of -8.45%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.49 in 2024Q2 from 0.49 in 2023Q4 representing a change of -9.26%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 500 million in 2024Q2 from 585 million in 2023Q4 representing a change of -14.51%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	5507994000	4892380000	12.58
total liabilities	1589282000	1453375000	9.35
total equity	3918712000	3439005000	13.95
cash and cash equivalents	2748262000	2450173000	12.17
short term investments	834942000	589172000	41.71
long term investments	9230000	6500000	42.00
total current assets	4278080000	3622671000	18.09
total non current assets	1229914000	1193403000	3.06
total current liabilities	1494996000	1350488000	10.70
total non current liabilities	94286000	102887000	-8.36
common stock	63812000	63450000	0.57
retained earnings	3380567000	2913166000	16.04
total debt	511534000	460176000	11.16

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 5,508 million in 2023 from 4,892 million in 2022 representing a change of 12.58%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 3,919 million in 2023 from 3,439 million in 2022 representing a change of 13.95%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 2,748 million in 2023 from 2,450 million in 2022 representing a change of 12.17%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 835 million in 2023 from 589 million in 2022 representing a change of 41.71%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 4,278 million in 2023 from 3,623 million in 2022 representing a change of 18.09%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 64 in 2023 from 63 in 2022 representing a change of 0.57%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 3,381 million in 2023 from 2,913 million in 2022 representing a change of 16.04%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,589 million in 2023 from 1,453 million in 2022 representing a change of 9.35%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 1,495 million in 2023 from 1,350 million in 2022 representing a change of 10.7%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 512 million in 2023 from 460 million in 2022 representing a change of 11.16%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	5489870000	5507994000	-0.33
total liabilities	1498775001	1589282000	-5.69
total equity	3991094999	3918712000	1.85
cash and cash equivalents	2595916000	2748262000	-5.54
short term investments	985318000	834942000	18.01
long term investments	19230000	9230000	108.34
total current assets	4243206000	4278080000	-0.82
total non current assets	1246664000	1229914000	1.36
total current liabilities	1386305000	1494996000	-7.27
total non current liabilities	112470001	94286000	19.29
common stock	66857000	63812000	4.77
retained earnings	3330128000	3140726000	6.03
total debt	515416000	511534000	0.76

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 5,490 million in 2024Q2 from 5,508 million in 2023Q4 representing a change of -0.33%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 2,596 million in 2024Q2 from 2,748 million in 2023Q4 representing a change of -5.54%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 4,243 million in 2024Q2 from 4,278 million in 2023Q4 representing a change of -0.82%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 515 million in 2024Q2 from 512 million in 2023Q4 representing a change of 0.76%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 1,499 million in 2024Q2 from 1,589 million in 2023Q4 representing a change of -5.69%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 3,991 million in 2024Q2 from 3,919 million in 2023Q4 representing a change of 1.85%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 985 million in 2024Q2 from 835 million in 2023Q4 representing a change of 18.01%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 1,386 million in 2024Q2 from 1,495 million in 2023Q4 representing a change of -7.27%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 67 in 2024Q2 from 64 in 2023Q4 representing a change of 4.77%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 3,330 million in 2024Q2 from 3,141 million in 2023Q4 representing a change of 6.03%. This indicates an accumulated profits.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	298089000	253850000	17.43
operating cash flow	818973000	947679000	-13.58
free cash flow	766409000	896090000	-14.47
capital expenditure	-52564000	-51589000	-1.89
depreciation and amortization	78089000	76355000	2.27
deferred income tax	0	-57183000	100.00
stock based compensation	0	-1784000	100.00
accounts payables	0	0	NaN
inventory	-102020000	-54904000	-85.82
acquisitions net	0	365672000	-100.00
investments in property plant and equipment	-52564000	-51589000	-1.89
net cash used for investing activites	-231772000	-368804000	37.16
debt repayment	62969000	-177352000	135.51
common stock issued	14202000	2638000	438.36
common stock repurchased	0	-29066000	100.00
dividends paid	-326249000	-127492000	-155.90
net cash used provided by financing activities	-280100000	-342205000	18.15
cash at end of period	2748262000	2450173000	12.17
accounts receivables	-1707000	113871000	-101.50
cash at beginning of period	2450173000	2196323000	11.56

Overall Score of Annual Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 298 million in 2023 from 254 million in 2022 representing a change of 17.43%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -53 million in 2023 from -52 million in 2022 representing a change of -1.89%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -2 million in 2023 from 114 million in 2022 representing a change of -101.5%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 819 million in 2023 from 948 million in 2022 representing a change of -13.58%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 766 million in 2023 from 896 million in 2022 representing a change of -14.47%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -57 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2023 from -2 million in 2022 representing a change of 100.0%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -326 million in 2023 from -127 million in 2022 representing a change of -155.9%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	350339000	564998000	-37.99
free cash flow	303418000	529209000	-42.67
capital expenditure	-46921000	-35789000	-31.10
depreciation and amortization	39865000	39412000	1.15
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	-1707000	100.00
accounts payables	0	0	NaN
inventory	0	-102020000	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-46921000	-35789000	-31.10
net cash used for investing activites	-159630000	-307389000	48.07
debt repayment	1397000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-450204000	-118184000	-280.93
net cash used provided by financing activities	-341786000	-142555000	-139.76
net change in cash	2595916000	0	NaN
cash at end of period	2595916000	2644196000	-1.83
cash at beginning of period	0	2644196000	-100.00

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,596 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -47 million in 2024Q2 from -36 million in 2023Q4 representing a change of -31.1%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 350 million in 2024Q2 from 565 million in 2023Q4 representing a change of -37.99%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 303 million in 2024Q2 from 529 million in 2023Q4 representing a change of -42.67%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -2 million in 2023Q4 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -450 million in 2024Q2 from -118 million in 2023Q4 representing a change of -280.93%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	3.24	2.96	9.33
net income per share	0.98	0.86	13.46
operating cash flow per share	1.02	1.2	-14.65
free cash flow per share	0.96	1.13	-15.53
cash per share	4.48	3.84	16.43
book value per share	4.9	4.35	12.54
tangible book value per share	4.54	3.96	14.82
shareholders equity per share	4.53	3.98	13.88
interest debt per share	0.67	0.6	11.69
market cap	3460032697.69	2827400746.05	22.38
enterprise value	1223304697.69	837403746.05	46.08
pe ratio	4.41	4.14	6.52
price to sales ratio	1.34	1.21	10.54
pocfratio	4.22	2.98	41.61
pfcf ratio	4.51	3.16	43.08
pb ratio	0.95	0.9	6.13
ptb ratio	0.95	0.9	6.13
ev to sales	0.47	0.36	31.96
enterprise value over ebitda	1.27	1.07	19.21
ev to operating cash flow	1.49	0.88	69.04
ev to free cash flow	1.6	0.93	70.80
earnings yield	0.23	0.24	-6.12
free cash flow yield	0.22	0.32	-30.11
debt to equity	0.14	0.15	-3.59
debt to assets	0.09	0.09	-1.26
net debt to ebitda	-2.32	-2.53	8.28
current ratio	2.86	2.68	6.68
interest coverage	41.62	65.44	-36.40
income quality	0.95	1.39	-31.67
dividend yield	0.09	0.05	109.11
payout ratio	0.42	0.19	122.75
sales general and administrative to revenue	0.12	0.14	-11.60
research and ddevelopement to revenue	0.04	0.05	-16.59
intangibles to total assets	0.05	0.06	-19.37
capex to operating cash flow	0.06	0.05	17.90
capex to revenue	0.02	0.02	-7.96
capex to depreciation	0.67	0.68	-0.37
stock based compensation to revenue	0	-0.0	100.00
graham number	9.99	8.79	13.67
roic	0.18	0.17	6.64
return on tangible assets	0.15	0.15	0.71
graham net net	2.96	2.43	21.59
working capital	2783084000	2272183000	22.49
tangible asset value	3635572000	3127101000	16.26
net current asset value	2688798000	2169296000	23.95
invested capital	3929932000	3459086000	13.61
average receivables	257700000	305394000	-15.62
average payables	71494500	63264500	13.01
average inventory	327375000	272641000	20.08
days sales outstanding	36.05	40.49	-10.97
days payables outstanding	45.38	37.9	19.71
days of inventory on hand	200.45	182.05	10.10
receivables turnover	10.12	9.01	12.32
payables turnover	8.04	9.63	-16.47
inventory turnover	1.82	2.0	-9.18
roe	0.22	0.22	-0.37
capex per share	0.07	0.07	0.63

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.22 on 2023-12-31 from 0.22 on 2022-12-31, representing a change of -0.37%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 4.41 on 2023-12-31 from 4.14 on 2022-12-31, representing a change of 6.52%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.86 on 2023-12-31 from 2.68 on 2022-12-31, representing a change of 6.68%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.14 on 2023-12-31 from 0.15 on 2022-12-31, representing a change of -3.59%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
1681.HK
calendar year	2024	2023	NaN
revenue per share	1.56	1.83	-14.44
net income per share	0.49	0.54	-9.20
operating cash flow per share	0.43	0.7	-38.51
free cash flow per share	0.37	0.66	-43.14
cash per share	4.42	4.46	-0.88
book value per share	4.92	4.87	1.01
tangible book value per share	4.59	4.38	4.78
shareholders equity per share	4.56	4.51	1.22
interest debt per share	0.64	0.64	-0.07
market cap	4223983477.45	3475750483.18	21.53
enterprise value	2143483477.45	1239022483.18	73.00
pe ratio	2.64	1.99	32.74
price to sales ratio	3.33	2.36	40.87
pocfratio	12.06	6.15	95.99
pfcf ratio	13.92	6.57	111.96
pb ratio	1.14	0.96	19.07
ptb ratio	1.14	0.96	19.07
ev to sales	1.69	0.84	100.53
enterprise value over ebitda	4.73	2.47	91.48
ev to operating cash flow	6.12	2.19	179.00
ev to free cash flow	7.06	2.34	201.74
earnings yield	0.09	0.13	-24.66
free cash flow yield	0.07	0.15	-52.82
debt to equity	0.14	0.14	-1.28
debt to assets	0.09	0.09	1.09
net debt to ebitda	-4.59	-4.46	-2.95
current ratio	3.06	2.86	6.96
interest coverage	0	0	NaN
income quality	0.88	1.29	-32.27
dividend yield	0.11	0.03	213.46
payout ratio	1.13	0.27	316.07
sales general and administrative to revenue	0.11	0.12	-12.69
research and ddevelopement to revenue	0.03	0.04	-21.63
intangibles to total assets	0.05	0.07	-31.66
capex to operating cash flow	0.13	0.06	111.43
capex to revenue	0.04	0.02	51.97
capex to depreciation	1.18	0.91	29.61
stock based compensation to revenue	0	0	NaN
graham number	7.12	7.42	-4.13
roic	0.09	0.1	-10.32
return on tangible assets	0.08	0.09	-10.35
graham net net	3.01	2.95	2.12
working capital	2856901000	2783084000	2.65
tangible asset value	3720396999	3521297000	5.65
net current asset value	2744430999	2688798000	2.07
invested capital	4003225000	3971290000	0.80
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	16.56	15.66	5.77
days payables outstanding	11.73	19.42	-39.58
days of inventory on hand	102.14	85.77	19.08
receivables turnover	5.43	5.75	-5.46
payables turnover	7.67	4.64	65.51
inventory turnover	0.88	1.05	-16.02
roe	0.11	0.12	-10.30
capex per share	0.06	0.04	30.02

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 2.64 on 2024-06-30 Q2 from 1.99 on 2023-12-31 Q4, representing a change of 32.74%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.14 on 2024-06-30 Q2 from 0.14 on 2023-12-31 Q4, representing a change of -1.28%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 3.06 on 2024-06-30 Q2 from 2.86 on 2023-12-31 Q4, representing a change of 6.96%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None